Tranexamic acid + Standard of Care
ApprovedCompleted 0 watching 0 views this week🔥 Hot
84
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Biliary Tract Surgical Procedures
Conditions
Biliary Tract Surgical Procedures, Pancreaticoduodenectomy, Esophagectomy, Colectomy, Gastrectomy
Trial Timeline
Sep 1, 2009 → May 1, 2011
NCT ID
NCT00827931About Tranexamic acid + Standard of Care
Tranexamic acid + Standard of Care is a approved stage product being developed by Pfizer for Biliary Tract Surgical Procedures. The current trial status is completed. This product is registered under clinical trial identifier NCT00827931. Target conditions include Biliary Tract Surgical Procedures, Pancreaticoduodenectomy, Esophagectomy.
Hype Score Breakdown
Clinical
30
Activity
20
Company
9
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00827931 | Approved | Completed |
Competing Products
20 competing products in Biliary Tract Surgical Procedures